Kapteyn-Murnane Laboratories, Inc. — Form D/A
Kapteyn-Murnane Laboratories, Inc. of BOULDER, CO, a company, filed a Form D amendment with the SEC on 2017-11-17. The offering totals $8.2M, of which $8.2M was reported sold. Industry: Other Technology.
Offering
- Filed: 2017-11-17
- Form: D/A
- Accession: 0001655428-17-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $8.2M
- Amount sold: $8.2M
- Minimum investment: $1.2M
- Investors: 4
- Date of first sale: 2015-10-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-249372
Issuer
- Name: Kapteyn-Murnane Laboratories, Inc.
- CIK: 0001655428
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4775 WALNUT ST UNIT 102, BOULDER, CO, 80301
- Phone: 303 544 9068
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Henry C Kapteyn | Director | Boulder, CO |
| Henry C Kapteyn | Executive Officer | Boulder, CO |
| Carly M Abrahamson | Director | Boulder, CO |
| Carly M Abrahamson | Executive Officer | Boulder, CO |
| Margaret M Murnane | Director | Boulder, CO |
| Margaret M Murnane | Executive Officer | Boulder, CO |
| Jackie M Sturm | Director | Boulder, CO |
| R.C. M Mercure | Director | Boulder, CO |
| R.C. M Mercure | Executive Officer | Boulder, CO |
| Alex M Andrianopoulos | Director | Boulder, CO |
| Barbara M Keller | Executive Officer | Boulder, CO |
| Ryan M Kirkpatrick | Director | Boulder, CO |
| Kevin M Fahey | Director | Boulder, CO |
| Kevin M Fahey | Executive Officer | Boulder, CO |
Other filings by this issuer (8)
More